Hitgen Inc.SSE: 688222

Report for Q3 2025

Oct 30, 2025 · Issued by Hitgen Inc. via Shanghai Stock Exchange

Filed with SSE · Oct 30, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-786

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Hitgen Inc. on 6ix

Earlier from Hitgen

HitGen Partner BioAge Labs Initiates Phase 1 Clinical Study of BGE-102, a Novel Brain-Penetrant NLRP3 inhibitorSep 15, 2025
Board of Supervisors' Verification Opinions and Publicity Explanation on List of Proposed Incentive Objects in 2025 Restricted Stock Incentive PlanSep 9, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1% ScaleSep 5, 2025
Advancing DEL Technology for the Research Lab: HitGen Introduces OpenDEL™ 5.0Aug 27, 2025
Announcement on Abnormal Fluctuations in Stock TradingJul 22, 2025

Later from Hitgen

All Hitgen news releases

Follow Hitgen into a list and get an email when it puts out news.

Follow Hitgen